CN Stock MarketDetailed Quotes

300702 Zhejiang Tianyu Pharmaceutical

Watchlist
  • 20.78
  • -0.34-1.61%
Market Closed May 10 15:00 CST
7.23BMarket Cap-223440P/E (TTM)

Zhejiang Tianyu Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-11.29%689.45M
-5.23%2.53B
-10.53%1.86B
-8.65%1.35B
3.64%777.21M
4.78%2.67B
7.45%2.08B
7.81%1.47B
-1.19%749.9M
-1.64%2.55B
Operating revenue
-11.29%689.45M
-5.23%2.53B
-10.53%1.86B
-8.65%1.35B
3.64%777.21M
4.78%2.67B
7.45%2.08B
7.81%1.47B
-1.19%749.9M
-1.64%2.55B
Other operating revenue
----
-56.05%6.74M
----
-79.00%1.56M
----
-7.01%15.33M
----
37.22%7.43M
----
1,103.10%16.49M
Total operating cost
-8.13%601.12M
-13.85%2.28B
-18.73%1.61B
-15.05%1.15B
-2.31%654.34M
12.70%2.64B
14.23%1.98B
14.56%1.35B
11.85%669.84M
23.90%2.35B
Operating cost
-6.33%445.9M
-22.33%1.54B
-26.91%1.12B
-23.47%811.08M
-4.53%476.04M
22.76%1.98B
27.12%1.53B
27.92%1.06B
12.99%498.63M
28.87%1.61B
Operating tax surcharges
-8.98%6.56M
84.39%33.17M
94.20%19.77M
141.27%13.08M
116.50%7.2M
-16.35%17.99M
-21.56%10.18M
-41.83%5.42M
-26.84%3.33M
-12.57%21.51M
Operating expense
84.97%24.44M
106.19%97.79M
81.65%61.21M
113.79%41.31M
37.94%13.21M
47.27%47.43M
21.87%33.69M
6.90%19.32M
3.87%9.58M
-3.42%32.2M
Administration expense
-10.32%76.82M
-12.94%330.13M
-23.33%210.46M
-15.52%151.98M
-14.11%85.65M
-12.94%379.2M
-15.24%274.49M
-14.07%179.91M
0.62%99.72M
18.21%435.54M
Financial expense
-113.44%-2.65M
462.92%36.34M
165.17%20.79M
151.77%9.21M
153.67%19.73M
-155.70%-10.01M
-741.38%-31.91M
-487.08%-17.79M
438.84%7.78M
-52.33%17.98M
-Interest expense (Financial expense)
20.65%14.23M
47.45%49.91M
51.04%35.22M
58.54%23.07M
69.71%11.8M
107.30%33.85M
165.74%23.32M
202.00%14.55M
201.01%6.95M
270.21%16.33M
-Interest Income (Financial expense)
-571.42%-11.54M
15.93%-6.07M
13.24%-4.73M
-5.31%-3.87M
8.19%-1.72M
28.17%-7.22M
32.29%-5.45M
44.77%-3.67M
58.06%-1.87M
-144.25%-10.05M
Research and development
-4.65%50.06M
5.50%243.82M
8.77%181.14M
15.48%122.32M
3.35%52.5M
1.63%231.1M
2.20%166.52M
-4.40%105.92M
8.13%50.8M
26.99%227.4M
Credit Impairment Loss
99.57%-15.39K
-262.67%-6.3M
-220.69%-5.54M
-164.30%-6.44M
-77.26%-3.6M
177.27%3.87M
274.97%4.59M
60.34%-2.44M
51.13%-2.03M
-14.51%-5.01M
Asset Impairment Loss
-127,504.58%-12.57M
-45.35%-140.22M
-2,426.25%-84.41M
-7,164.09%-45.88M
--9.87K
-279.96%-96.47M
-462.69%-3.34M
-6.37%-631.64K
----
-249.46%-25.39M
Other net revenue
-762.92%-28.45M
-43.97%-178.05M
-317.28%-152.69M
-1,260.88%-96.04M
-77.87%4.29M
-395.14%-123.67M
-197.10%-36.59M
-133.73%-7.06M
681.83%19.39M
-49.22%41.9M
Fair value change income
-46.80%6.28M
66.50%-10.03M
9.43%-47.82M
-22.74%-40.64M
1,031.42%11.8M
-130.88%-29.94M
-131.60%-52.8M
-39.18%-33.11M
103.86%1.04M
-130.41%-12.97M
Invest income
-196.64%-26.38M
-77.23%-52.66M
-486.88%-33.58M
-214.05%-16.26M
-161.49%-8.89M
-145.24%-29.71M
-110.76%-5.72M
-68.22%14.26M
-41.71%14.46M
155.31%65.68M
-Including: Investment income associates
31.87%-796.08K
20.18%-5.22M
-30.98%-3.93M
-211.64%-2.34M
---1.17M
-203.10%-6.54M
-194.49%-3M
-52.51%-751.23K
----
-802.61%-2.16M
Asset deal income
-99.84%42.04
-18.44%-29.39K
-136.88%-86.23K
-82.12%41.81K
151.40%26.29K
-141.40%-24.82K
290.02%233.79K
290.02%233.79K
-24.73%10.46K
-70.90%59.94K
Other revenue
-14.26%4.25M
9.06%31.19M
-8.32%18.75M
-10.21%13.14M
-16.18%4.95M
46.44%28.6M
95.37%20.45M
123.95%14.63M
94.31%5.91M
-23.70%19.53M
Operating profit
-52.91%59.89M
169.47%70.75M
55.01%100.79M
-11.32%101.37M
27.87%127.17M
-142.42%-101.83M
-73.10%65.02M
-44.89%114.31M
-36.54%99.45M
-69.05%240.08M
Add:Non operating Income
-7.53%98.09K
225.44%6.1M
-50.37%247.06K
-35.92%161.41K
-66.90%106.08K
29.46%1.88M
475.94%497.79K
459.40%251.88K
3,338.44%320.49K
21.34%1.45M
Less:Non operating expense
-95.14%56.56K
-53.22%4.93M
-15.48%4.18M
25.49%3.87M
114.04%1.16M
-54.39%10.55M
0.83%4.95M
11.38%3.09M
-23.42%543.78K
186.74%23.12M
Total profit
-52.48%59.93M
165.08%71.92M
59.91%96.85M
-12.40%97.65M
27.09%126.11M
-150.60%-110.5M
-74.43%60.57M
-45.54%111.47M
-36.40%99.23M
-71.59%218.41M
Less:Income tax cost
-24.97%19.41M
432.44%44.56M
28.68%28.06M
78.79%29.54M
78.36%25.87M
-39.06%8.37M
-29.36%21.8M
-31.39%16.52M
-35.69%14.51M
-86.51%13.73M
Net profit
-59.58%40.52M
FLtoP27.36M
77.47%68.8M
-28.26%68.11M
18.31%100.24M
SL-118.87M
-81.19%38.76M
-47.43%94.95M
-36.52%84.72M
-69.32%204.68M
Net profit from continuing operation
-59.58%40.52M
123.02%27.36M
77.47%68.8M
-28.26%68.11M
18.31%100.24M
-158.08%-118.87M
-81.19%38.76M
-47.43%94.95M
-36.52%84.72M
-69.32%204.68M
Net profit of parent company owners
-59.58%40.52M
123.02%27.36M
77.47%68.8M
-28.26%68.11M
18.31%100.24M
-158.08%-118.87M
-81.19%38.76M
-47.43%94.95M
-36.52%84.72M
-69.32%204.68M
Earning per share
Basic earning per share
-59.88%0.1164
123.53%0.08
81.82%0.2
-25.93%0.2
19.14%0.2901
-157.63%-0.34
-81.36%0.11
-48.08%0.27
-64.71%0.2435
-71.36%0.59
Diluted earning per share
-59.88%0.1164
123.53%0.08
81.82%0.2
-25.93%0.2
19.14%0.2901
-157.63%-0.34
-81.36%0.11
-48.08%0.27
-64.19%0.2435
-71.22%0.59
Other composite income
0.83
Other composite income of parent company owners
----
--0.83
----
----
----
----
----
----
----
----
Total composite income
-59.58%40.52M
123.02%27.36M
77.47%68.8M
-28.26%68.11M
18.31%100.24M
-158.08%-118.87M
-81.19%38.76M
-47.43%94.95M
-36.52%84.72M
-69.32%204.68M
Total composite income of parent company owners
-59.58%40.52M
123.02%27.36M
77.47%68.8M
-28.26%68.11M
18.31%100.24M
-158.08%-118.87M
-81.19%38.76M
-47.43%94.95M
-36.52%84.72M
-69.32%204.68M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -11.29%689.45M-5.23%2.53B-10.53%1.86B-8.65%1.35B3.64%777.21M4.78%2.67B7.45%2.08B7.81%1.47B-1.19%749.9M-1.64%2.55B
Operating revenue -11.29%689.45M-5.23%2.53B-10.53%1.86B-8.65%1.35B3.64%777.21M4.78%2.67B7.45%2.08B7.81%1.47B-1.19%749.9M-1.64%2.55B
Other operating revenue -----56.05%6.74M-----79.00%1.56M-----7.01%15.33M----37.22%7.43M----1,103.10%16.49M
Total operating cost -8.13%601.12M-13.85%2.28B-18.73%1.61B-15.05%1.15B-2.31%654.34M12.70%2.64B14.23%1.98B14.56%1.35B11.85%669.84M23.90%2.35B
Operating cost -6.33%445.9M-22.33%1.54B-26.91%1.12B-23.47%811.08M-4.53%476.04M22.76%1.98B27.12%1.53B27.92%1.06B12.99%498.63M28.87%1.61B
Operating tax surcharges -8.98%6.56M84.39%33.17M94.20%19.77M141.27%13.08M116.50%7.2M-16.35%17.99M-21.56%10.18M-41.83%5.42M-26.84%3.33M-12.57%21.51M
Operating expense 84.97%24.44M106.19%97.79M81.65%61.21M113.79%41.31M37.94%13.21M47.27%47.43M21.87%33.69M6.90%19.32M3.87%9.58M-3.42%32.2M
Administration expense -10.32%76.82M-12.94%330.13M-23.33%210.46M-15.52%151.98M-14.11%85.65M-12.94%379.2M-15.24%274.49M-14.07%179.91M0.62%99.72M18.21%435.54M
Financial expense -113.44%-2.65M462.92%36.34M165.17%20.79M151.77%9.21M153.67%19.73M-155.70%-10.01M-741.38%-31.91M-487.08%-17.79M438.84%7.78M-52.33%17.98M
-Interest expense (Financial expense) 20.65%14.23M47.45%49.91M51.04%35.22M58.54%23.07M69.71%11.8M107.30%33.85M165.74%23.32M202.00%14.55M201.01%6.95M270.21%16.33M
-Interest Income (Financial expense) -571.42%-11.54M15.93%-6.07M13.24%-4.73M-5.31%-3.87M8.19%-1.72M28.17%-7.22M32.29%-5.45M44.77%-3.67M58.06%-1.87M-144.25%-10.05M
Research and development -4.65%50.06M5.50%243.82M8.77%181.14M15.48%122.32M3.35%52.5M1.63%231.1M2.20%166.52M-4.40%105.92M8.13%50.8M26.99%227.4M
Credit Impairment Loss 99.57%-15.39K-262.67%-6.3M-220.69%-5.54M-164.30%-6.44M-77.26%-3.6M177.27%3.87M274.97%4.59M60.34%-2.44M51.13%-2.03M-14.51%-5.01M
Asset Impairment Loss -127,504.58%-12.57M-45.35%-140.22M-2,426.25%-84.41M-7,164.09%-45.88M--9.87K-279.96%-96.47M-462.69%-3.34M-6.37%-631.64K-----249.46%-25.39M
Other net revenue -762.92%-28.45M-43.97%-178.05M-317.28%-152.69M-1,260.88%-96.04M-77.87%4.29M-395.14%-123.67M-197.10%-36.59M-133.73%-7.06M681.83%19.39M-49.22%41.9M
Fair value change income -46.80%6.28M66.50%-10.03M9.43%-47.82M-22.74%-40.64M1,031.42%11.8M-130.88%-29.94M-131.60%-52.8M-39.18%-33.11M103.86%1.04M-130.41%-12.97M
Invest income -196.64%-26.38M-77.23%-52.66M-486.88%-33.58M-214.05%-16.26M-161.49%-8.89M-145.24%-29.71M-110.76%-5.72M-68.22%14.26M-41.71%14.46M155.31%65.68M
-Including: Investment income associates 31.87%-796.08K20.18%-5.22M-30.98%-3.93M-211.64%-2.34M---1.17M-203.10%-6.54M-194.49%-3M-52.51%-751.23K-----802.61%-2.16M
Asset deal income -99.84%42.04-18.44%-29.39K-136.88%-86.23K-82.12%41.81K151.40%26.29K-141.40%-24.82K290.02%233.79K290.02%233.79K-24.73%10.46K-70.90%59.94K
Other revenue -14.26%4.25M9.06%31.19M-8.32%18.75M-10.21%13.14M-16.18%4.95M46.44%28.6M95.37%20.45M123.95%14.63M94.31%5.91M-23.70%19.53M
Operating profit -52.91%59.89M169.47%70.75M55.01%100.79M-11.32%101.37M27.87%127.17M-142.42%-101.83M-73.10%65.02M-44.89%114.31M-36.54%99.45M-69.05%240.08M
Add:Non operating Income -7.53%98.09K225.44%6.1M-50.37%247.06K-35.92%161.41K-66.90%106.08K29.46%1.88M475.94%497.79K459.40%251.88K3,338.44%320.49K21.34%1.45M
Less:Non operating expense -95.14%56.56K-53.22%4.93M-15.48%4.18M25.49%3.87M114.04%1.16M-54.39%10.55M0.83%4.95M11.38%3.09M-23.42%543.78K186.74%23.12M
Total profit -52.48%59.93M165.08%71.92M59.91%96.85M-12.40%97.65M27.09%126.11M-150.60%-110.5M-74.43%60.57M-45.54%111.47M-36.40%99.23M-71.59%218.41M
Less:Income tax cost -24.97%19.41M432.44%44.56M28.68%28.06M78.79%29.54M78.36%25.87M-39.06%8.37M-29.36%21.8M-31.39%16.52M-35.69%14.51M-86.51%13.73M
Net profit -59.58%40.52MFLtoP27.36M77.47%68.8M-28.26%68.11M18.31%100.24MSL-118.87M-81.19%38.76M-47.43%94.95M-36.52%84.72M-69.32%204.68M
Net profit from continuing operation -59.58%40.52M123.02%27.36M77.47%68.8M-28.26%68.11M18.31%100.24M-158.08%-118.87M-81.19%38.76M-47.43%94.95M-36.52%84.72M-69.32%204.68M
Net profit of parent company owners -59.58%40.52M123.02%27.36M77.47%68.8M-28.26%68.11M18.31%100.24M-158.08%-118.87M-81.19%38.76M-47.43%94.95M-36.52%84.72M-69.32%204.68M
Earning per share
Basic earning per share -59.88%0.1164123.53%0.0881.82%0.2-25.93%0.219.14%0.2901-157.63%-0.34-81.36%0.11-48.08%0.27-64.71%0.2435-71.36%0.59
Diluted earning per share -59.88%0.1164123.53%0.0881.82%0.2-25.93%0.219.14%0.2901-157.63%-0.34-81.36%0.11-48.08%0.27-64.19%0.2435-71.22%0.59
Other composite income 0.83
Other composite income of parent company owners ------0.83--------------------------------
Total composite income -59.58%40.52M123.02%27.36M77.47%68.8M-28.26%68.11M18.31%100.24M-158.08%-118.87M-81.19%38.76M-47.43%94.95M-36.52%84.72M-69.32%204.68M
Total composite income of parent company owners -59.58%40.52M123.02%27.36M77.47%68.8M-28.26%68.11M18.31%100.24M-158.08%-118.87M-81.19%38.76M-47.43%94.95M-36.52%84.72M-69.32%204.68M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg